Vision: Retina Implant AG wins E.U. approval for sight-restoring microchip
Retinal Implant AG wins its 1st CE Mark for a wireless sub-retinal implant that reverses blindness caused by retinitis pigmentosa.
European healthcare regulators this month granted CE Mark approval to Retina Implant AG's Alpha IMS, a tiny eye implant that restores "useful" vision in patients blinded by retinitis pigmentosa.
Reutlingen, Germany-based Retina Implant AG, founded in 2003 from a German research institute spinout, touts the technology as "artificial sight." The Alpha IMS chip is implanted beneath the retina, where it sends electrical impulses to the brain to help restore visual capacity.